Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Sterilization and Disinfection Control75.12M34.75%
Clinical Genomics52.59M24.33%
Calibration Solutions47.76M22.09%
Biopharmaceutical Development40.71M18.83%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States106.4M49.21%
Other84.86M39.25%
People's Republic of China24.93M11.53%
